Related Experiment Video
Updated: May 4, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.5K
Obesity in the elderly: more complicated than you think
1Bariatric and Metabolic Institute, Cleveland Clinic.
Cleveland Clinic Journal of Medicine
|January 7, 2014
Summary
Obesity in older adults is increasing but lacks a clear definition due to age-related body composition changes. Treatment remains controversial because of the obesity paradox and limited guidelines.
Area of Science:
- Gerontology
- Obesity Medicine
- Aging Research
Background:
- Rising prevalence of obesity among the elderly population.
- Lack of a standardized definition for obesity in older adults.
- Association between aging, sarcopenia (muscle loss/fat gain), and obesity.
Purpose of the Study:
- To address the definitional ambiguity of obesity in the elderly.
- To explore the complexities surrounding the treatment of obesity in older adults.
- To investigate the implications of the obesity paradox in this demographic.
Main Methods:
- Review of current literature on geriatric obesity.
- Analysis of sarcopenia's role in defining obesity in aging.
- Examination of existing treatment guidelines and controversies.
Main Results:
- Current definitions of obesity may not accurately apply to older adults.
- Sarcopenia complicates the assessment and definition of obesity in the elderly.
- The obesity paradox presents challenges to standard obesity treatment protocols.
Conclusions:
- A specific definition for obesity in older adults is needed.
- Treatment strategies for geriatric obesity require careful consideration due to unique physiological changes.
- Further research is essential to resolve the obesity paradox and establish evidence-based guidelines.
Related Concept Videos
01:24Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
01:21Drug Dosing: Obese Patients
368
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
01:15Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
367
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367